Research ArticleArticle
Inhibition of IκB Kinase-Nuclear Factor-κB Signaling Pathway by 3,5-Bis(2-flurobenzylidene)piperidin-4-one (EF24), a Novel Monoketone Analog of Curcumin
Andrea L. Kasinski, Yuhong Du, Shala L. Thomas, Jing Zhao, Shi-Yong Sun, Fadlo R. Khuri, Cun-Yu Wang, Mamoru Shoji, Aiming Sun, James P. Snyder, Dennis Liotta and Haian Fu
Molecular Pharmacology September 2008, 74 (3) 654-661; DOI: https://doi.org/10.1124/mol.108.046201
Andrea L. Kasinski
Graduate Programs in Genetics and Molecular Biology (A.L.K.) and Molecular and Systems Pharmacology (S.L.T.), Departments of Pharmacology (Y.D., J.Z., H.F.), Hematology and Oncology (S.-Y.S., F.R.K., M.S.), and Chemistry (A.S., J.P.S., D.L.), and Emory Chemical Biology Discovery Center (Y.D., A.S., J.P.S., D.L., H.F.), Emory University, Atlanta, Georgia; and Division of Oral Biology and Medicine, University of California Los Angeles Dentistry, Los Angeles, California (C.-Y.W.)
Yuhong Du
Graduate Programs in Genetics and Molecular Biology (A.L.K.) and Molecular and Systems Pharmacology (S.L.T.), Departments of Pharmacology (Y.D., J.Z., H.F.), Hematology and Oncology (S.-Y.S., F.R.K., M.S.), and Chemistry (A.S., J.P.S., D.L.), and Emory Chemical Biology Discovery Center (Y.D., A.S., J.P.S., D.L., H.F.), Emory University, Atlanta, Georgia; and Division of Oral Biology and Medicine, University of California Los Angeles Dentistry, Los Angeles, California (C.-Y.W.)
Shala L. Thomas
Graduate Programs in Genetics and Molecular Biology (A.L.K.) and Molecular and Systems Pharmacology (S.L.T.), Departments of Pharmacology (Y.D., J.Z., H.F.), Hematology and Oncology (S.-Y.S., F.R.K., M.S.), and Chemistry (A.S., J.P.S., D.L.), and Emory Chemical Biology Discovery Center (Y.D., A.S., J.P.S., D.L., H.F.), Emory University, Atlanta, Georgia; and Division of Oral Biology and Medicine, University of California Los Angeles Dentistry, Los Angeles, California (C.-Y.W.)
Jing Zhao
Graduate Programs in Genetics and Molecular Biology (A.L.K.) and Molecular and Systems Pharmacology (S.L.T.), Departments of Pharmacology (Y.D., J.Z., H.F.), Hematology and Oncology (S.-Y.S., F.R.K., M.S.), and Chemistry (A.S., J.P.S., D.L.), and Emory Chemical Biology Discovery Center (Y.D., A.S., J.P.S., D.L., H.F.), Emory University, Atlanta, Georgia; and Division of Oral Biology and Medicine, University of California Los Angeles Dentistry, Los Angeles, California (C.-Y.W.)
Shi-Yong Sun
Graduate Programs in Genetics and Molecular Biology (A.L.K.) and Molecular and Systems Pharmacology (S.L.T.), Departments of Pharmacology (Y.D., J.Z., H.F.), Hematology and Oncology (S.-Y.S., F.R.K., M.S.), and Chemistry (A.S., J.P.S., D.L.), and Emory Chemical Biology Discovery Center (Y.D., A.S., J.P.S., D.L., H.F.), Emory University, Atlanta, Georgia; and Division of Oral Biology and Medicine, University of California Los Angeles Dentistry, Los Angeles, California (C.-Y.W.)
Fadlo R. Khuri
Graduate Programs in Genetics and Molecular Biology (A.L.K.) and Molecular and Systems Pharmacology (S.L.T.), Departments of Pharmacology (Y.D., J.Z., H.F.), Hematology and Oncology (S.-Y.S., F.R.K., M.S.), and Chemistry (A.S., J.P.S., D.L.), and Emory Chemical Biology Discovery Center (Y.D., A.S., J.P.S., D.L., H.F.), Emory University, Atlanta, Georgia; and Division of Oral Biology and Medicine, University of California Los Angeles Dentistry, Los Angeles, California (C.-Y.W.)
Cun-Yu Wang
Graduate Programs in Genetics and Molecular Biology (A.L.K.) and Molecular and Systems Pharmacology (S.L.T.), Departments of Pharmacology (Y.D., J.Z., H.F.), Hematology and Oncology (S.-Y.S., F.R.K., M.S.), and Chemistry (A.S., J.P.S., D.L.), and Emory Chemical Biology Discovery Center (Y.D., A.S., J.P.S., D.L., H.F.), Emory University, Atlanta, Georgia; and Division of Oral Biology and Medicine, University of California Los Angeles Dentistry, Los Angeles, California (C.-Y.W.)
Mamoru Shoji
Graduate Programs in Genetics and Molecular Biology (A.L.K.) and Molecular and Systems Pharmacology (S.L.T.), Departments of Pharmacology (Y.D., J.Z., H.F.), Hematology and Oncology (S.-Y.S., F.R.K., M.S.), and Chemistry (A.S., J.P.S., D.L.), and Emory Chemical Biology Discovery Center (Y.D., A.S., J.P.S., D.L., H.F.), Emory University, Atlanta, Georgia; and Division of Oral Biology and Medicine, University of California Los Angeles Dentistry, Los Angeles, California (C.-Y.W.)
Aiming Sun
Graduate Programs in Genetics and Molecular Biology (A.L.K.) and Molecular and Systems Pharmacology (S.L.T.), Departments of Pharmacology (Y.D., J.Z., H.F.), Hematology and Oncology (S.-Y.S., F.R.K., M.S.), and Chemistry (A.S., J.P.S., D.L.), and Emory Chemical Biology Discovery Center (Y.D., A.S., J.P.S., D.L., H.F.), Emory University, Atlanta, Georgia; and Division of Oral Biology and Medicine, University of California Los Angeles Dentistry, Los Angeles, California (C.-Y.W.)
James P. Snyder
Graduate Programs in Genetics and Molecular Biology (A.L.K.) and Molecular and Systems Pharmacology (S.L.T.), Departments of Pharmacology (Y.D., J.Z., H.F.), Hematology and Oncology (S.-Y.S., F.R.K., M.S.), and Chemistry (A.S., J.P.S., D.L.), and Emory Chemical Biology Discovery Center (Y.D., A.S., J.P.S., D.L., H.F.), Emory University, Atlanta, Georgia; and Division of Oral Biology and Medicine, University of California Los Angeles Dentistry, Los Angeles, California (C.-Y.W.)
Dennis Liotta
Graduate Programs in Genetics and Molecular Biology (A.L.K.) and Molecular and Systems Pharmacology (S.L.T.), Departments of Pharmacology (Y.D., J.Z., H.F.), Hematology and Oncology (S.-Y.S., F.R.K., M.S.), and Chemistry (A.S., J.P.S., D.L.), and Emory Chemical Biology Discovery Center (Y.D., A.S., J.P.S., D.L., H.F.), Emory University, Atlanta, Georgia; and Division of Oral Biology and Medicine, University of California Los Angeles Dentistry, Los Angeles, California (C.-Y.W.)
Haian Fu
Graduate Programs in Genetics and Molecular Biology (A.L.K.) and Molecular and Systems Pharmacology (S.L.T.), Departments of Pharmacology (Y.D., J.Z., H.F.), Hematology and Oncology (S.-Y.S., F.R.K., M.S.), and Chemistry (A.S., J.P.S., D.L.), and Emory Chemical Biology Discovery Center (Y.D., A.S., J.P.S., D.L., H.F.), Emory University, Atlanta, Georgia; and Division of Oral Biology and Medicine, University of California Los Angeles Dentistry, Los Angeles, California (C.-Y.W.)
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
Inhibition of IκB Kinase-Nuclear Factor-κB Signaling Pathway by 3,5-Bis(2-flurobenzylidene)piperidin-4-one (EF24), a Novel Monoketone Analog of Curcumin
Andrea L. Kasinski, Yuhong Du, Shala L. Thomas, Jing Zhao, Shi-Yong Sun, Fadlo R. Khuri, Cun-Yu Wang, Mamoru Shoji, Aiming Sun, James P. Snyder, Dennis Liotta and Haian Fu
Molecular Pharmacology September 1, 2008, 74 (3) 654-661; DOI: https://doi.org/10.1124/mol.108.046201
Research ArticleArticle
Inhibition of IκB Kinase-Nuclear Factor-κB Signaling Pathway by 3,5-Bis(2-flurobenzylidene)piperidin-4-one (EF24), a Novel Monoketone Analog of Curcumin
Andrea L. Kasinski, Yuhong Du, Shala L. Thomas, Jing Zhao, Shi-Yong Sun, Fadlo R. Khuri, Cun-Yu Wang, Mamoru Shoji, Aiming Sun, James P. Snyder, Dennis Liotta and Haian Fu
Molecular Pharmacology September 1, 2008, 74 (3) 654-661; DOI: https://doi.org/10.1124/mol.108.046201
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement